Advertisements



Divis Labs tanks 20% after USFDA issues import alert on Vizag unit

The stock tanked 20% to Rs 635, also its 52-week low on BSE in intra-day on back of heavy volumes......»»

Category: topSource: business-standardMar 21st, 2017

Resolved all issues leading to USFDA import alert on Vizag unit: Divis Labs

BS ReporterHyderabad, 20 September: Hyderabad-based Divis Laboratories Limited on Wednesday said Unit 2 in Visakhapatnam, which has been under import alert for the past six months, has resolved all the previous observations of.....»»

Category: topSource: business-standardSep 20th, 2017

USFDA adds one more clause to import alert on Divi"s Labs

BS ReporterHyderabad, 22 March: The US Food and Drug Administration(US FDA) has invoked one more clause with regard to the import alert issued to Unit-2 of Hyderabad-based Divis Laboratories Limited, this time charging the company w.....»»

Category: topSource: business-standardMar 22nd, 2017

Divi"s Labs barred from exports to US after FDA import alert on Vizag unit

Hyderabad, 21 March:In a big setback to Hyderabad-based active pharmaceutical ingredients(APIs) maker Divis Laboratories Limited, the US Food and Drug Administration(US FDA) has issued import alert on the company's Unit 2 facility.....»»

Category: topSource: business-standardMar 21st, 2017

Divis Labs surges as USFDA to lift import alert at Visakhapatnam facility

The stock surges 20% to Rs 816 on BSE in intra-day trade.....»»

Category: topSource: business-standardJul 10th, 2017

USFDA issues warning letter to Divis Labs for Vishakhapatnam unit

Company, however, did not provide details of the warning letter.....»»

Category: topSource: business-standardApr 22nd, 2017

One-third of Divi"s scrip value melts down in two sessions

Possible import alert after USFDA remarks about firm's Vizag unit drags stock down to two-year low.....»»

Category: topSource: business-standardDec 26th, 2016

A third of Divi"s scrip value evaporates in two trading sessions

Possible import alert after USFDA remarks about firm's Vizag unit drags stock down to two-year low.....»»

Category: topSource: business-standardDec 26th, 2016

USFDA issues alert on Dr Reddy"s Hyderabad unit

Recently, USFDA had issued a Form-483 with two observations after inspecting co's unit.....»»

Category: topSource: business-standardApr 29th, 2017

US FDA issues warning letter for Divi"s Laboratories" Visakhapatnam unit

Last month, US drug regulator had issued an import alert on the products manufactured from this unit.....»»

Category: topSource: business-standardApr 24th, 2017

Divi"s Labs" Vizag unit gets warning letter from USFDA

BS Reporter Hyderabad, 22 AprilDivi'sLaboratories has informed the stock exchanges that the US drug regulator hasissued a warning letter for its unit-II at Visakhapatnam, Andhra Pradesh. "We willrespond to this warning letter with .....»»

Category: topSource: business-standardApr 22nd, 2017

USFDA warning to Wockhardt"s Ankleshwar plant over data integrity issues

Three of firm's units under import alert; FDA cites failure to check microbiological contamination.....»»

Category: topSource: business-standardJan 3rd, 2017

Dr Reddy"s Labs gains as Srikakulam SEZ Unit II get EIR from USFDA

The stock moved higher by nearly 7% to Rs 2,466 on BSE in an otherwise weak market.....»»

Category: topSource: business-standardSep 21st, 2017

Divi"s Labs surges 6% on successful USFDA inspection of Unit-2

The stock trading at its highest level since December 23, 2016, has outperformed the market by surging 47% in past one month, as compared to 4% rise in Sensex......»»

Category: topSource: business-standardSep 20th, 2017

Laurus Labs gets USFDA nod for Visakhapatnam unit

The firm is one of the leading manufacturers of APIs for anti-retroviral (ARV), Hepatitis C, and Oncology.....»»

Category: topSource: business-standardSep 15th, 2017

USFDA issues warning letter to Telangana unit of Vista Pharmaceuticals

The USFDA has issued a warning letter to the manufacturing facility of the city-based Vista Pharmaceuticals Ltd, for "significant violations" of current good manufacturing practice (CGMP) regulations for finished pharmaceuticals.....»»

Category: personnelSource: nytJul 12th, 2017

Ipca Labs nears 52-week low on USFDA bans import of drugs from three plants

The stock tanked 15% to Rs 437 on BSE in intra-day trade on back of heavy volumes.....»»

Category: topSource: business-standardJun 16th, 2017

USFDA sounds alert on quality issues in Indian pharma

Warning letters might increase as 190 units are expected to be inspected in next three years.....»»

Category: topSource: business-standardApr 8th, 2017

Indoco Remedies falls over 15% on import alert for Goa unit

The stock tanked 16% to Rs 208.50, also its 52-week low on the NSE in early morning trade.....»»

Category: topSource: business-standardApr 3rd, 2017

USFDA to lift import alert on Sun Pharma"s Mohali plant

The drug major had inherited the facility as part of its acquisition of Ranbaxy in 2015.....»»

Category: topSource: business-standardMar 14th, 2017

Sun Pharma surges 7% as USFDA to lift import alert on Mohali facility

The stock moved higher by 7% to Rs 729 on the NSE on back of heavy volumes......»»

Category: topSource: business-standardMar 14th, 2017